Home > Boards > US OTC > Medical - Healthcare >


Add WNDM Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 4/15/2018 10:57:23 AM - Followers: 16 - Board type: Free - Posts Today: 0



Wound Management Technologies, Inc. is an emerging commercial stage company with its primary products in the $5B worldwide advanced wound care market. Wound Management's primary focus is the distribution of its unique, patented collagen product, CellerateRX®, which is FDA cleared and reimbursable under Medicare Part B. Wound Management has other advanced biotech products in development including a patented resorbable bone wax line that is in late stages of development, as well as a subsidiary focused on technology for secure healthcare communications, data collaboration and storage.

Rapid revenue growth is projected from our leading FDA cleared CellerateRX wound care products, which recent market and clinical validations show to be clinically cost effective with broad uses. CellerateRX has a competitive proprietary feature and performance advantages over other collagen-based products. It is available in powder (95% collagen) and gel (65%) forms that don't need special handling (like refrigeration). It is active in all 4 phases of wound healing. As CellerateRX revenues grow, the company is positioned to become cash flow positive and profitable in 12-18 months.

CellerateRx Activated Collagen targets a multi-billion dollar domestic and international wound care market with over 60% profit margins. A large part of the growth in the wound care markets is from diabetic ulcers.  In people with compromised health or circulation, the difference in wound healing can be significant. You can read through numerous evidence-based studies on the website.

Wound Management Activates Orthopedic Business; Partner Chosen to Develop Products Based on its Patent; Initial License Fee Received

FORT WORTH, Texas, November 11, 2011 PRNewswire-FirstCall -

Wound Management Technologies, Inc., (OTCQB: WNDM | WNDM.PK) a leading innovator in advanced wound care solutions, today announced that its subsidiary, Resorbable Orthopedic Products, LLC, has entered into a Development and License Agreement with Newport Beach, CA-based BioStructures, LLC to develop products for bone remodeling in the human skeletal system based on ROP's patent.  BioStructures has paid ROP an initial $100K licensing fee and the agreement calls for ROP to receive additional license fees as well as royalties on sales throughout the life of the patent.  Under this contract, minimum royalties will begin in 2013 and last until 2023. Initial commercial sales from this business are expected in 2013.

"This transaction allows us to combine our portfolio of proprietary biomaterials with a patented resorbable wax carrier.  The combination of these products will further enhance the dynamic product lineup of BioStructures," said Russell Cook, CEO of BioStructures, LLC.

"We are pleased to have reached a license agreement with BioStructures to develop many of the orthopedic products related to Resorbable Orthopedic Products' patent on resorbable bone wax and bone void fillers. This agreement is the first commercial agreement for our subsidiary ROP and marks the start of a second product line for WNDM," said Deborah Hutchinson, president of Wound Management Technologies.  "We believe that BioStructures is the right partner to develop and market these important orthopedic products and we look forward to strong success of these products in the marketplace."

ROP's patent was developed by WNDM advisor Barry Constantine and his associates and was acquired by WNDM in 2009. Mr. Constantine will oversee ROP's development responsibilities with BioStructures.  "Commercialization of the BioStructures product containing the ROP technology in addition to the development and commercialization of other embodiments within the ROP patent advances the practice of orthopedic surgery," said Barry Constantine. "We are excited to see our technology move into product development with BioStructures."

Resorbable Orthopedic Products may commercialize additional products covered by the patent, including a resorbable orthopedic hemostat (resorbable bone wax), a resorbable orthopedic hemostat antimicrobial dressing and products for the veterinary market.


Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
WNDM News: Initial Statement of Beneficial Ownership (3) 04/19/2018 10:17:59 AM
WNDM News: Current Report Filing (8-k) 04/16/2018 12:08:14 PM
WNDM News: Annual Report (10-k) 03/29/2018 05:14:43 PM
WNDM News: Current Report Filing (8-k) 02/21/2018 03:43:12 PM
WNDM News: Quarterly Report (10-q) 11/16/2017 04:27:52 PM
News News Alert: Initial Statement of Beneficial Ownership (3) 04/19/2018 10:17:59 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#732   I agree on the share count. The new toddski 04/15/18 10:57:22 AM
#731   As in a reverse split? I don't know!...R/S's PithicusKong 04/09/18 11:45:02 AM
#730   Does anyone know or done the dd on snack 04/09/18 10:58:03 AM
#729   52 week high .75 is a scam misprint!! BIGHUNGRY 04/08/18 02:09:55 PM
#728   I am pretty sure that basic is what PithicusKong 04/07/18 10:32:02 PM
#727   I could see that. Net income alone toddski 04/07/18 09:17:44 AM
#726   Investor impatience, FANG stocks, computer auto trading, chasing PithicusKong 04/07/18 09:03:48 AM
#725   I'm honestly surprised this is still a 5 toddski 04/06/18 08:14:52 PM
#724   Yes I read the article, it shows this _Predator_ 04/04/18 08:09:36 AM
#723   Name change to WNDM Medical....more in keeping with PithicusKong 04/03/18 09:55:53 PM
#722   Wndm .50 cents within six months. The company _Predator_ 04/02/18 06:14:49 PM
#721   52 week HIGH.75 false misprint!! 5 year BIGHUNGRY 03/31/18 03:33:37 PM
#720   Considering their latest Annual report it is a PithicusKong 03/31/18 02:19:18 PM
#719   It also says if this wart medication hasn't BIGHUNGRY 03/30/18 12:48:00 PM
#718   I used the Scamitology chart! The outcome it BIGHUNGRY 03/30/18 12:45:20 PM
#717   If you are going to post anything on PithicusKong 03/30/18 12:24:33 PM
#716 a nickle, it's great investment! Thanks for SunScents 03/30/18 12:16:49 PM
#715   Actually 5 years it hasn't been over 11 cents!!!! BIGHUNGRY 03/30/18 12:02:14 PM
#714   It says 52 week high is .75. Yet BIGHUNGRY 03/30/18 11:37:50 AM
#713   But we all have to sell Monday because PithicusKong 03/30/18 10:33:22 AM
#712   OK...thanks. Appreciate the response. Have a great long weekend. PithicusKong 03/30/18 10:28:54 AM
#711   Some companies like Fidelity on their platforms give traderking60 03/30/18 07:56:20 AM
#710   Positive annual report! _Predator_ 03/30/18 07:42:04 AM
#709   That was an excellent annual report. Finally we've SunScents 03/30/18 07:40:31 AM
#708   Not other stocks, other trade platforms. PithicusKong 03/29/18 09:42:38 PM
#707   Yikes getting pumped! BIGHUNGRY 03/29/18 08:42:36 PM
#706   Yes, that pertains to the bid or the traderking60 03/29/18 06:15:00 PM
#705   Just to clarify....that goes for bid and ask? PithicusKong 03/29/18 03:13:42 PM
#704   This will grow definitely, strong hands will make _Predator_ 03/29/18 07:57:32 AM
#703   Low volume.....trader interest has waned and that could PithicusKong 03/28/18 09:52:39 PM
#702   Thanks....I am used to the Nasdaq where everything PithicusKong 03/28/18 04:08:00 PM
#701   Will only show if bid is for 10,000 traderking60 03/28/18 02:37:44 PM
#700   I’m not sure how but that is definitely _Predator_ 03/28/18 09:50:46 AM
#699   Well that settles it for me.....even with a PithicusKong 03/28/18 09:39:09 AM
#698   This AM should show if there is any PithicusKong 03/28/18 09:25:31 AM
#697   I wish I had the possibility of finding PithicusKong 03/27/18 09:41:33 PM
#696   Definitely something fishy going on! I cannot believe _Predator_ 03/27/18 04:46:46 PM
#695   And a trade just went through for 4,400 PithicusKong 03/27/18 03:53:48 PM
#694   There's something screwed up about the OTC trading PithicusKong 03/27/18 01:28:21 PM
#693   Yep, maybe they will. But, first they'd have SunScents 03/26/18 10:12:18 AM
#692   Maybe this company will reopen and help the BIGHUNGRY 03/24/18 02:06:35 PM
#691   I like neosporin it dominates this stuff! BIGHUNGRY 03/20/18 05:12:35 PM
#690   Then listen up, pay attention, and stop making PithicusKong 03/20/18 03:06:50 PM
#689   You started I'm here for good! BIGHUNGRY 03/20/18 01:28:29 PM
#688   Unfortunately you are too "thick" to understand. Go PithicusKong 03/20/18 01:20:01 PM
#687   Lubriderm vasoline this company same thing. BIGHUNGRY 03/20/18 01:17:34 PM
#686   Cellerate RX is used in the OR.....Lubriderm is PithicusKong 03/20/18 01:00:34 PM
#685   It's true for you because you are a PithicusKong 03/20/18 12:38:52 PM
#684   I prefer lubriderm! BIGHUNGRY 03/20/18 12:21:22 PM
#683   Out of business for years lol _Predator_ 03/20/18 12:19:09 PM